CYTONICS
Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan Complex Test (FACT) for molecular discography and FACT Plus multi analyte assay for diagnosing the source of pain in the spine and joints. Additionally, the company provides proteomics research and development services. Cytonics Corporation was founded in 2006 and is based in Jupiter, Florida.
CYTONICS
Industry:
Biotechnology Fitness Health Diagnostics
Founded:
2006-01-01
Address:
Jupiter, Florida, United States
Country:
United States
Website Url:
http://www.cytonics.com
Total Employee:
51+
Status:
Active
Contact:
5612831204
Email Addresses:
[email protected]
Total Funding:
3.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Kibow Biotech
Kibow Biotech is a biotechnology company based in suburban Philadelphia that produces scientifically-formulated .
Current Employees Featured
Founder
Investors List
SeedInvest
SeedInvest investment in Series C - Cytonics
Rainmakers
Rainmakers investment in Seed Round - Cytonics
Official Site Inspections
http://www.cytonics.com Semrush global rank: 1.2 M Semrush visits lastest month: 25.56 K
- Host name: cloudhost-10344892.us-midwest-2.nxcli.net
- IP address: 199.189.225.164
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cytonics"
Home - New - Cytonics Corporation
Cytonics has received over $15M in funding to-date, including $1.8M in grants from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). …See details»
Cytonics - Crunchbase Company Profile & Funding
Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan …See details»
Management - Cytonics Corporation
Cytonics recently welcomed Tracy Goeken, MD to the company’s Board of Directors. As a member of the Board, Dr. Goeken will help drive the company’s direction and manage clinical trials. ... a contract research organization that …See details»
cytonics.com Reviews: Is this site a scam or legit?
About - Cytonics Corporation
Cytonics is a privately held biotechnology company specializing in the development of diagnostics and therapeutics for osteoarthritis (OA), a disease of the joints that renders the afflicted …See details»
Cytonics 2025 Company Profile: Valuation, Funding
Cytonics has raised $34.2M. Who are Cytonics’s investors? River VC, The Rainmakers ( Application Software) , DePuy Synthes , National Institutes of Arthritis and Musculoskeletal Diseases, and National Institutes of Neurological …See details»
Cytonics - Funding, Financials, Valuation & Investors - Crunchbase
Cytonics is a biotechnology company developing diagnostic assays focusing on musculoskeletal-related pain. New. ... Log In. Log In. Experience the new Crunchbase, powered by AI . …See details»
Cytonics - Contacts, Employees, Board Members, Advisors & Alumni
Cytonics is a biotechnology company developing diagnostic assays focusing on musculoskeletal-related pain. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. …See details»
Cytonics | The Future of Regenerative Medicine
Cytonics is developing diagnostics and therapeutic medicine for osteoarthritis. Disrupting a $240B industry by pioneering the future of regenerative medicine. Final Day for Early Investor Perks. …See details»
Cytonics Corporation – In this blog series, we will …
Mar 8, 2025 Cytonics Corporation’s Phase 1 clinical trial of CYT-108 for osteoarthritis reports no adverse events among patients, with 14 out of 22 receiving the maximum of two doses. The therapy, genetically engineered to …See details»
Technology - Cytonics Corporation
We have contracted a research organization, Goodwin Biotechnology, to purify industrial-scale quantities of CYT-108 for pre-clinical experiments and FDA clinical trials. Keys to …See details»
#28 The Business of Biotech (4th ... - Cytonics Corporation
May 1, 2024 The CEO of Cytonics, Joey Bose, navigates a day filled with challenges in spearheading the company’s mission. From managing emails and operations to engaging in …See details»
#6 Meet The Cytonics Triumvirate - Cytonics Corporation
Jan 2, 2024 In the competitive world of biopharmaceutical R&D, Cytonics is taking on Big Pharma in the fight against osteoarthritis. Led by Dr. Gaetano Scuderi, Joey Bose, and Dr. …See details»
Cytonics - Crunchbase Company Profile & Funding
Organization. Cytonics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. ... Cytonics engages in PC-controlled micropattern light irradiation device …See details»
Cytonics Announces Launch of Regulation A+ Equity …
12 hours ago Cytonics, founded in 2006, is a private research and development company focused on developing molecular diagnostics and therapeutics for chronic musculoskeletal …See details»
Cytonics CYT-108: A Unique Approach to OA Treatment
Jan 11, 2024 Moe Alsumidaie: Could you elaborate on the current phase and progress of the CYT-108 clinical trial in osteoarthritis treatment? Joey Bose: Cytonics has recombinantly …See details»
Become a Shareholder – Cytonics Corporation
Cytonics has received over $25M in funding to date, including $1.8M from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). Now, we are …See details»
Cytonics on StartEngine 2025 - Kingscrowd
Cytonics has created an Autologous Platelet Integrated Concentration system concentrating A2M from patients’ blood to treat their own damaged joints. The company has a strong IP portfolio …See details»
FAQ - Cytonics Corporation
Cytonics has received over $25M in funding to date, including $1.8M from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). Now, we are …See details»
Cytonics Receives Feedback from the FDA on Pre ... - Cytonics …
NOVEMBER 2, 2018 Jupiter, FL: Cytonics Corporation received feedback on the pre-clinical and clinical trial designs for their recombinant Alpha-2-Macroglobulin (A2M) drug product, Cyt-108. …See details»